The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Skin Substitutes from Biological Sources Market Research Report 2025

Global Skin Substitutes from Biological Sources Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1964445

No of Pages : 93

Ask Your Query
Synopsis
Biological skin consists of the outer epidermis and/or dermis (the layer of skin between the epidermis and subcutaneous tissue) embedded in an acellular matrix (supporting structure) to form a biological skin substitute. Products are made from a variety of sources, including human tissue (from patients or others), non-human tissue (bovine, porcine, horse), synthetic materials (man-made), or a combination of these materials.
The global Skin Substitutes from Biological Sources market was valued at US$ 1717 million in 2023 and is anticipated to reach US$ 3712 million by 2030, witnessing a CAGR of 11.8% during the forecast period 2024-2030.
North American market for Skin Substitutes from Biological Sources is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Skin Substitutes from Biological Sources is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Skin Substitutes from Biological Sources in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Skin Substitutes from Biological Sources include Allergan (AbbVie), AlloSource, Organogenesis, BD, Smith & Nephew, Integra LifeSciences, Synthes (Johnson & Johnson), Axogen, Vericel Corporation, LifeNet Health, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Skin Substitutes from Biological Sources, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Skin Substitutes from Biological Sources.
The Skin Substitutes from Biological Sources market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Skin Substitutes from Biological Sources market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Skin Substitutes from Biological Sources companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan (AbbVie)
AlloSource
Organogenesis
BD
Smith & Nephew
Integra LifeSciences
Synthes (Johnson & Johnson)
Axogen
Vericel Corporation
LifeNet Health
MTF Biologics
Arthrex
Wright Medical Group NV (Stryker)
Cook Biotech Incorporated
Aroa Biosurgery
Surgalign Holdings
Anika Therapeutics
Forticell Bioscience
MLM Biologics
Promethean LifeSciences
Segment by Type
Allogeneic Acellular Cells
Xenogeneic Cells
Allogeneic Cells
Autologous Cells
Segment by Application
Hospitals
Specialty Clinics
Wound Care Centers
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Skin Substitutes from Biological Sources company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Skin Substitutes from Biological Sources Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Allogeneic Acellular Cells
1.2.3 Xenogeneic Cells
1.2.4 Allogeneic Cells
1.2.5 Autologous Cells
1.3 Market by Application
1.3.1 Global Skin Substitutes from Biological Sources Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Wound Care Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Skin Substitutes from Biological Sources Market Perspective (2019-2030)
2.2 Global Skin Substitutes from Biological Sources Growth Trends by Region
2.2.1 Global Skin Substitutes from Biological Sources Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Skin Substitutes from Biological Sources Historic Market Size by Region (2019-2024)
2.2.3 Skin Substitutes from Biological Sources Forecasted Market Size by Region (2025-2030)
2.3 Skin Substitutes from Biological Sources Market Dynamics
2.3.1 Skin Substitutes from Biological Sources Industry Trends
2.3.2 Skin Substitutes from Biological Sources Market Drivers
2.3.3 Skin Substitutes from Biological Sources Market Challenges
2.3.4 Skin Substitutes from Biological Sources Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Skin Substitutes from Biological Sources Players by Revenue
3.1.1 Global Top Skin Substitutes from Biological Sources Players by Revenue (2019-2024)
3.1.2 Global Skin Substitutes from Biological Sources Revenue Market Share by Players (2019-2024)
3.2 Global Skin Substitutes from Biological Sources Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Skin Substitutes from Biological Sources Revenue
3.4 Global Skin Substitutes from Biological Sources Market Concentration Ratio
3.4.1 Global Skin Substitutes from Biological Sources Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Skin Substitutes from Biological Sources Revenue in 2023
3.5 Global Key Players of Skin Substitutes from Biological Sources Head office and Area Served
3.6 Global Key Players of Skin Substitutes from Biological Sources, Product and Application
3.7 Global Key Players of Skin Substitutes from Biological Sources, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Skin Substitutes from Biological Sources Breakdown Data by Type
4.1 Global Skin Substitutes from Biological Sources Historic Market Size by Type (2019-2024)
4.2 Global Skin Substitutes from Biological Sources Forecasted Market Size by Type (2025-2030)
5 Skin Substitutes from Biological Sources Breakdown Data by Application
5.1 Global Skin Substitutes from Biological Sources Historic Market Size by Application (2019-2024)
5.2 Global Skin Substitutes from Biological Sources Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Skin Substitutes from Biological Sources Market Size (2019-2030)
6.2 North America Skin Substitutes from Biological Sources Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Skin Substitutes from Biological Sources Market Size by Country (2019-2024)
6.4 North America Skin Substitutes from Biological Sources Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Skin Substitutes from Biological Sources Market Size (2019-2030)
7.2 Europe Skin Substitutes from Biological Sources Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Skin Substitutes from Biological Sources Market Size by Country (2019-2024)
7.4 Europe Skin Substitutes from Biological Sources Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Skin Substitutes from Biological Sources Market Size (2019-2030)
8.2 Asia-Pacific Skin Substitutes from Biological Sources Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Skin Substitutes from Biological Sources Market Size by Region (2019-2024)
8.4 Asia-Pacific Skin Substitutes from Biological Sources Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Skin Substitutes from Biological Sources Market Size (2019-2030)
9.2 Latin America Skin Substitutes from Biological Sources Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Skin Substitutes from Biological Sources Market Size by Country (2019-2024)
9.4 Latin America Skin Substitutes from Biological Sources Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Skin Substitutes from Biological Sources Market Size (2019-2030)
10.2 Middle East & Africa Skin Substitutes from Biological Sources Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Skin Substitutes from Biological Sources Market Size by Country (2019-2024)
10.4 Middle East & Africa Skin Substitutes from Biological Sources Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan (AbbVie)
11.1.1 Allergan (AbbVie) Company Details
11.1.2 Allergan (AbbVie) Business Overview
11.1.3 Allergan (AbbVie) Skin Substitutes from Biological Sources Introduction
11.1.4 Allergan (AbbVie) Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.1.5 Allergan (AbbVie) Recent Development
11.2 AlloSource
11.2.1 AlloSource Company Details
11.2.2 AlloSource Business Overview
11.2.3 AlloSource Skin Substitutes from Biological Sources Introduction
11.2.4 AlloSource Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.2.5 AlloSource Recent Development
11.3 Organogenesis
11.3.1 Organogenesis Company Details
11.3.2 Organogenesis Business Overview
11.3.3 Organogenesis Skin Substitutes from Biological Sources Introduction
11.3.4 Organogenesis Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.3.5 Organogenesis Recent Development
11.4 BD
11.4.1 BD Company Details
11.4.2 BD Business Overview
11.4.3 BD Skin Substitutes from Biological Sources Introduction
11.4.4 BD Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.4.5 BD Recent Development
11.5 Smith & Nephew
11.5.1 Smith & Nephew Company Details
11.5.2 Smith & Nephew Business Overview
11.5.3 Smith & Nephew Skin Substitutes from Biological Sources Introduction
11.5.4 Smith & Nephew Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.5.5 Smith & Nephew Recent Development
11.6 Integra LifeSciences
11.6.1 Integra LifeSciences Company Details
11.6.2 Integra LifeSciences Business Overview
11.6.3 Integra LifeSciences Skin Substitutes from Biological Sources Introduction
11.6.4 Integra LifeSciences Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.6.5 Integra LifeSciences Recent Development
11.7 Synthes (Johnson & Johnson)
11.7.1 Synthes (Johnson & Johnson) Company Details
11.7.2 Synthes (Johnson & Johnson) Business Overview
11.7.3 Synthes (Johnson & Johnson) Skin Substitutes from Biological Sources Introduction
11.7.4 Synthes (Johnson & Johnson) Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.7.5 Synthes (Johnson & Johnson) Recent Development
11.8 Axogen
11.8.1 Axogen Company Details
11.8.2 Axogen Business Overview
11.8.3 Axogen Skin Substitutes from Biological Sources Introduction
11.8.4 Axogen Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.8.5 Axogen Recent Development
11.9 Vericel Corporation
11.9.1 Vericel Corporation Company Details
11.9.2 Vericel Corporation Business Overview
11.9.3 Vericel Corporation Skin Substitutes from Biological Sources Introduction
11.9.4 Vericel Corporation Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.9.5 Vericel Corporation Recent Development
11.10 LifeNet Health
11.10.1 LifeNet Health Company Details
11.10.2 LifeNet Health Business Overview
11.10.3 LifeNet Health Skin Substitutes from Biological Sources Introduction
11.10.4 LifeNet Health Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.10.5 LifeNet Health Recent Development
11.11 MTF Biologics
11.11.1 MTF Biologics Company Details
11.11.2 MTF Biologics Business Overview
11.11.3 MTF Biologics Skin Substitutes from Biological Sources Introduction
11.11.4 MTF Biologics Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.11.5 MTF Biologics Recent Development
11.12 Arthrex
11.12.1 Arthrex Company Details
11.12.2 Arthrex Business Overview
11.12.3 Arthrex Skin Substitutes from Biological Sources Introduction
11.12.4 Arthrex Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.12.5 Arthrex Recent Development
11.13 Wright Medical Group NV (Stryker)
11.13.1 Wright Medical Group NV (Stryker) Company Details
11.13.2 Wright Medical Group NV (Stryker) Business Overview
11.13.3 Wright Medical Group NV (Stryker) Skin Substitutes from Biological Sources Introduction
11.13.4 Wright Medical Group NV (Stryker) Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.13.5 Wright Medical Group NV (Stryker) Recent Development
11.14 Cook Biotech Incorporated
11.14.1 Cook Biotech Incorporated Company Details
11.14.2 Cook Biotech Incorporated Business Overview
11.14.3 Cook Biotech Incorporated Skin Substitutes from Biological Sources Introduction
11.14.4 Cook Biotech Incorporated Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.14.5 Cook Biotech Incorporated Recent Development
11.15 Aroa Biosurgery
11.15.1 Aroa Biosurgery Company Details
11.15.2 Aroa Biosurgery Business Overview
11.15.3 Aroa Biosurgery Skin Substitutes from Biological Sources Introduction
11.15.4 Aroa Biosurgery Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.15.5 Aroa Biosurgery Recent Development
11.16 Surgalign Holdings
11.16.1 Surgalign Holdings Company Details
11.16.2 Surgalign Holdings Business Overview
11.16.3 Surgalign Holdings Skin Substitutes from Biological Sources Introduction
11.16.4 Surgalign Holdings Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.16.5 Surgalign Holdings Recent Development
11.17 Anika Therapeutics
11.17.1 Anika Therapeutics Company Details
11.17.2 Anika Therapeutics Business Overview
11.17.3 Anika Therapeutics Skin Substitutes from Biological Sources Introduction
11.17.4 Anika Therapeutics Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.17.5 Anika Therapeutics Recent Development
11.18 Forticell Bioscience
11.18.1 Forticell Bioscience Company Details
11.18.2 Forticell Bioscience Business Overview
11.18.3 Forticell Bioscience Skin Substitutes from Biological Sources Introduction
11.18.4 Forticell Bioscience Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.18.5 Forticell Bioscience Recent Development
11.19 MLM Biologics
11.19.1 MLM Biologics Company Details
11.19.2 MLM Biologics Business Overview
11.19.3 MLM Biologics Skin Substitutes from Biological Sources Introduction
11.19.4 MLM Biologics Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.19.5 MLM Biologics Recent Development
11.20 Promethean LifeSciences
11.20.1 Promethean LifeSciences Company Details
11.20.2 Promethean LifeSciences Business Overview
11.20.3 Promethean LifeSciences Skin Substitutes from Biological Sources Introduction
11.20.4 Promethean LifeSciences Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.20.5 Promethean LifeSciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
List of Tables
Table 1. Global Skin Substitutes from Biological Sources Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Allogeneic Acellular Cells
Table 3. Key Players of Xenogeneic Cells
Table 4. Key Players of Allogeneic Cells
Table 5. Key Players of Autologous Cells
Table 6. Global Skin Substitutes from Biological Sources Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Skin Substitutes from Biological Sources Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Skin Substitutes from Biological Sources Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Skin Substitutes from Biological Sources Market Share by Region (2019-2024)
Table 10. Global Skin Substitutes from Biological Sources Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Skin Substitutes from Biological Sources Market Share by Region (2025-2030)
Table 12. Skin Substitutes from Biological Sources Market Trends
Table 13. Skin Substitutes from Biological Sources Market Drivers
Table 14. Skin Substitutes from Biological Sources Market Challenges
Table 15. Skin Substitutes from Biological Sources Market Restraints
Table 16. Global Skin Substitutes from Biological Sources Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Skin Substitutes from Biological Sources Market Share by Players (2019-2024)
Table 18. Global Top Skin Substitutes from Biological Sources Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Skin Substitutes from Biological Sources as of 2023)
Table 19. Ranking of Global Top Skin Substitutes from Biological Sources Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Skin Substitutes from Biological Sources Revenue (CR5 and HHI) & (2019-2024)
Table 21. Global Key Players of Skin Substitutes from Biological Sources, Headquarters and Area Served
Table 22. Global Key Players of Skin Substitutes from Biological Sources, Product and Application
Table 23. Global Key Players of Skin Substitutes from Biological Sources, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Skin Substitutes from Biological Sources Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Skin Substitutes from Biological Sources Revenue Market Share by Type (2019-2024)
Table 27. Global Skin Substitutes from Biological Sources Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Skin Substitutes from Biological Sources Revenue Market Share by Type (2025-2030)
Table 29. Global Skin Substitutes from Biological Sources Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Skin Substitutes from Biological Sources Revenue Market Share by Application (2019-2024)
Table 31. Global Skin Substitutes from Biological Sources Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Skin Substitutes from Biological Sources Revenue Market Share by Application (2025-2030)
Table 33. North America Skin Substitutes from Biological Sources Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Skin Substitutes from Biological Sources Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Skin Substitutes from Biological Sources Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Skin Substitutes from Biological Sources Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Skin Substitutes from Biological Sources Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Skin Substitutes from Biological Sources Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Skin Substitutes from Biological Sources Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Skin Substitutes from Biological Sources Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Skin Substitutes from Biological Sources Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Skin Substitutes from Biological Sources Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Skin Substitutes from Biological Sources Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Skin Substitutes from Biological Sources Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Skin Substitutes from Biological Sources Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Skin Substitutes from Biological Sources Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Skin Substitutes from Biological Sources Market Size by Country (2025-2030) & (US$ Million)
Table 48. Allergan (AbbVie) Company Details
Table 49. Allergan (AbbVie) Business Overview
Table 50. Allergan (AbbVie) Skin Substitutes from Biological Sources Product
Table 51. Allergan (AbbVie) Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
Table 52. Allergan (AbbVie) Recent Development
Table 53. AlloSource Company Details
Table 54. AlloSource Business Overview
Table 55. AlloSource Skin Substitutes from Biological Sources Product
Table 56. AlloSource Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
Table 57. AlloSource Recent Development
Table 58. Organogenesis Company Details
Table 59. Organogenesis Business Overview
Table 60. Organogenesis Skin Substitutes from Biological Sources Product
Table 61. Organogenesis Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
Table 62. Organogenesis Recent Development
Table 63. BD Company Details
Table 64. BD Business Overview
Table 65. BD Skin Substitutes from Biological Sources Product
Table 66. BD Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
Table 67. BD Recent Development
Table 68. Smith & Nephew Company Details
Table 69. Smith & Nephew Business Overview
Table 70. Smith & Nephew Skin Substitutes from Biological Sources Product
Table 71. Smith & Nephew Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
Table 72. Smith & Nephew Recent Development
Table 73. Integra LifeSciences Company Details
Table 74. Integra LifeSciences Business Overview
Table 75. Integra LifeSciences Skin Substitutes from Biological Sources Product
Table 76. Integra LifeSciences Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
Table 77. Integra LifeSciences Recent Development
Table 78. Synthes (Johnson & Johnson) Company Details
Table 79. Synthes (Johnson & Johnson) Business Overview
Table 80. Synthes (Johnson & Johnson) Skin Substitutes from Biological Sources Product
Table 81. Synthes (Johnson & Johnson) Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
Table 82. Synthes (Johnson & Johnson) Recent Development
Table 83. Axogen Company Details
Table 84. Axogen Business Overview
Table 85. Axogen Skin Substitutes from Biological Sources Product
Table 86. Axogen Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
Table 87. Axogen Recent Development
Table 88. Vericel Corporation Company Details
Table 89. Vericel Corporation Business Overview
Table 90. Vericel Corporation Skin Substitutes from Biological Sources Product
Table 91. Vericel Corporation Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
Table 92. Vericel Corporation Recent Development
Table 93. LifeNet Health Company Details
Table 94. LifeNet Health Business Overview
Table 95. LifeNet Health Skin Substitutes from Biological Sources Product
Table 96. LifeNet Health Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
Table 97. LifeNet Health Recent Development
Table 98. MTF Biologics Company Details
Table 99. MTF Biologics Business Overview
Table 100. MTF Biologics Skin Substitutes from Biological Sources Product
Table 101. MTF Biologics Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
Table 102. MTF Biologics Recent Development
Table 103. Arthrex Company Details
Table 104. Arthrex Business Overview
Table 105. Arthrex Skin Substitutes from Biological Sources Product
Table 106. Arthrex Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
Table 107. Arthrex Recent Development
Table 108. Wright Medical Group NV (Stryker) Company Details
Table 109. Wright Medical Group NV (Stryker) Business Overview
Table 110. Wright Medical Group NV (Stryker) Skin Substitutes from Biological Sources Product
Table 111. Wright Medical Group NV (Stryker) Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
Table 112. Wright Medical Group NV (Stryker) Recent Development
Table 113. Cook Biotech Incorporated Company Details
Table 114. Cook Biotech Incorporated Business Overview
Table 115. Cook Biotech Incorporated Skin Substitutes from Biological Sources Product
Table 116. Cook Biotech Incorporated Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
Table 117. Cook Biotech Incorporated Recent Development
Table 118. Aroa Biosurgery Company Details
Table 119. Aroa Biosurgery Business Overview
Table 120. Aroa Biosurgery Skin Substitutes from Biological Sources Product
Table 121. Aroa Biosurgery Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
Table 122. Aroa Biosurgery Recent Development
Table 123. Surgalign Holdings Company Details
Table 124. Surgalign Holdings Business Overview
Table 125. Surgalign Holdings Skin Substitutes from Biological Sources Product
Table 126. Surgalign Holdings Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
Table 127. Surgalign Holdings Recent Development
Table 128. Anika Therapeutics Company Details
Table 129. Anika Therapeutics Business Overview
Table 130. Anika Therapeutics Skin Substitutes from Biological Sources Product
Table 131. Anika Therapeutics Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
Table 132. Anika Therapeutics Recent Development
Table 133. Forticell Bioscience Company Details
Table 134. Forticell Bioscience Business Overview
Table 135. Forticell Bioscience Skin Substitutes from Biological Sources Product
Table 136. Forticell Bioscience Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
Table 137. Forticell Bioscience Recent Development
Table 138. MLM Biologics Company Details
Table 139. MLM Biologics Business Overview
Table 140. MLM Biologics Skin Substitutes from Biological Sources Product
Table 141. MLM Biologics Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
Table 142. MLM Biologics Recent Development
Table 143. Promethean LifeSciences Company Details
Table 144. Promethean LifeSciences Business Overview
Table 145. Promethean LifeSciences Skin Substitutes from Biological Sources Product
Table 146. Promethean LifeSciences Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
Table 147. Promethean LifeSciences Recent Development
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report


List of Figures
Figure 1. Skin Substitutes from Biological Sources Picture
Figure 2. Global Skin Substitutes from Biological Sources Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Skin Substitutes from Biological Sources Market Share by Type: 2023 VS 2030
Figure 4. Allogeneic Acellular Cells Features
Figure 5. Xenogeneic Cells Features
Figure 6. Allogeneic Cells Features
Figure 7. Autologous Cells Features
Figure 8. Global Skin Substitutes from Biological Sources Market Size by Application (2024-2030) & (US$ Million)
Figure 9. Global Skin Substitutes from Biological Sources Market Share by Application: 2023 VS 2030
Figure 10. Hospitals Case Studies
Figure 11. Specialty Clinics Case Studies
Figure 12. Wound Care Centers Case Studies
Figure 13. Skin Substitutes from Biological Sources Report Years Considered
Figure 14. Global Skin Substitutes from Biological Sources Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Skin Substitutes from Biological Sources Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Skin Substitutes from Biological Sources Market Share by Region: 2023 VS 2030
Figure 17. Global Skin Substitutes from Biological Sources Market Share by Players in 2023
Figure 18. Global Top Skin Substitutes from Biological Sources Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Skin Substitutes from Biological Sources as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Skin Substitutes from Biological Sources Revenue in 2023
Figure 20. North America Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Skin Substitutes from Biological Sources Market Share by Country (2019-2030)
Figure 22. United States Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Skin Substitutes from Biological Sources Market Share by Country (2019-2030)
Figure 26. Germany Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Skin Substitutes from Biological Sources Market Share by Region (2019-2030)
Figure 34. China Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Skin Substitutes from Biological Sources Market Share by Country (2019-2030)
Figure 42. Mexico Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Skin Substitutes from Biological Sources Market Share by Country (2019-2030)
Figure 46. Turkey Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. UAE Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Allergan (AbbVie) Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
Figure 50. AlloSource Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
Figure 51. Organogenesis Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
Figure 52. BD Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
Figure 53. Smith & Nephew Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
Figure 54. Integra LifeSciences Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
Figure 55. Synthes (Johnson & Johnson) Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
Figure 56. Axogen Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
Figure 57. Vericel Corporation Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
Figure 58. LifeNet Health Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
Figure 59. MTF Biologics Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
Figure 60. Arthrex Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
Figure 61. Wright Medical Group NV (Stryker) Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
Figure 62. Cook Biotech Incorporated Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
Figure 63. Aroa Biosurgery Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
Figure 64. Surgalign Holdings Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
Figure 65. Anika Therapeutics Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
Figure 66. Forticell Bioscience Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
Figure 67. MLM Biologics Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
Figure 68. Promethean LifeSciences Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock